West Nile Virus Victim Urges Awareness of GenoMed's Trial
GenoMed (PINKSHEETS: GMED), a Next-Generation Disease Management company whose business is public health(TM), today joined Sgt. Donnie Manry, a Bryan, Texas policeman recovering from paralysis due to West Nile virus, in urging greater public awareness of GenoMed's clinical trial for West Nile virus encephalitis.
Sgt. Manry contracted West Nile virus encephalitis in July 2006, becoming paralyzed from the waist down. Three weeks after his first symptoms, Sgt. Manry and his physician began GenoMed's treatment protocol, which they credit with speeding his recovery. But despite heroic effort, Sgt. Manry still cannot walk without assistance nearly a year later.
Sgt. Manry, who is scheduled to lose his police job in two months because of his continued paralysis, said, "I don't want anybody to have to go through what I did. I just wish I'd known about GenoMed's protocol sooner."
Added Sgt. Manry, "In my case it took over a week before West Nile virus was even confirmed. GenoMed's treatment should be started as a precautionary measure even before confirmation by the CDC lab."
Said GenoMed's CEO and Chief Medical Officer, David Moskowitz MD, "Mr. Manry has put in a superhuman effort to recover from this devastating disease, which has been well documented (http://www.topix.net/search/article?q=%22Donnie+Manry%22, and donniemanry.info). Our experience with other patients suggests that he would have gotten a lot better a lot faster if he'd begun our treatment right away, within the first two days rather than three weeks later."
Added Dr. Moskowitz, "The sooner brain inflammation is turned off, the lower the risk of paralysis. Knowing about our treatment ahead of time could make the difference between a quick recovery instead of prolonged paralysis." |
